SCHEMBL539283

SCHEMBL539283

CCCCCCCCCCCCCCCCCCOc1cc(OCCCCCCCCCCCCCCCCCC)cc(C(Cl)(c2ccc(Cl)cc2)c2ccc(Cl)cc2)c1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 2/20 0.44
NR5A1 Q13285 1/20 0.41
TSHR P16473 2/20 0.41
BLM P54132 1/20 0.40
THRB P10828 1/20 0.39
CNR1 P21554 4/20 0.38
CNR2 P34972 4/20 0.38
TP53 P04637 1/20 0.38
KMT2A Q03164 1/20 0.38
LTA4H P09960 1/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HSD17B10 Q99714 1/20 0.37
PLA2G4B P0C869 1/20 0.37
GAA P10253 1/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15470861 0.92 MEN1 (0.39) PLA2G2ANR5A1TSHRTHRBCNR1
SCHEMBL318324 0.87 PLA2G2A (0.49) PLA2G2ANR5A1TSHRBLMCNR1
SCHEMBL13165994 0.85 PLA2G2A (0.44) PLA2G2ANR5A1TSHRBLMTHRB
SCHEMBL538922 0.83 ESR1 (0.40) THRBKMT2ARAB9ASMN1; SMN2
SCHEMBL15470859 0.81 ESR1 (0.44) THRBCNR1CNR2KMT2ARAB9A
SCHEMBL5599322 0.77 NR5A1 (0.66) NR5A1TSHRTP53LTA4HNPC1
SCHEMBL6122097 0.77 NR5A1 (0.66) NR5A1TSHRTP53LTA4HNPC1
SCHEMBL11662072 0.77 NR5A1 (0.66) NR5A1TSHRTP53LTA4HNPC1
SCHEMBL9304906 0.77 LTA4H (0.60) NR5A1TSHRCNR1TP53LTA4H
SCHEMBL18302044 0.77 LTA4H (0.60) NR5A1TSHRCNR1TP53LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9029504-B2 Fluorene compound AJINOMOTO CO., INC. (JP) 2015-05-12 US disclosed
US-20140046022-A1 FLUORENE COMPOUND AJINOMOTO CO., INC. (JP) 2014-02-13 US disclosed
US-8569453-B2 Fluorene compound AJINOMOTO CO., INC. (JP) 2013-10-29 US disclosed
US-8569453-B2 Fluorene compound AJINOMOTO CO., INC. (JP) 2013-10-29 US disclosed
EP-2415744-A1 FLUORENE COMPOUND Ajinomoto Co., Inc. (JP) 2012-02-08 EP disclosed
US-20100240867-A1 FLUORENE COMPOUND AJINOMOTO CO. INC. (JP) 2010-09-23 US disclosed
US-20100240867-A1 FLUORENE COMPOUND AJINOMOTO CO. INC. (JP) 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140046022-A1 FLUORENE COMPOUND NPPA, FURIN, SFPQ PLA2G2A 4293/4885NR5A1 3555/4885TSHR 1689/4885
US-20100240867-A1 FLUORENE COMPOUND NPPA, FURIN, SFPQ PLA2G2A 4293/4885NR5A1 3555/4885TSHR 1689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.